DONG GUE OH: Open Payments
NPI 1952966293 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Luye Pharma (USA) Ltd. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Alkermes, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: REXULTI, ERZOFRI EXTENDED-RELEASE, SPRAVATO, CAPLYTA, ARISTADA, VRAYLAR.
Industry payments across IL — which companies pay providers there.
